年龄相关性黄斑变性临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 年龄相关性黄斑变性（国际通用名 age-related macular degeneration）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖黄斑变性、AMD等说法。
正在招募的年龄相关性黄斑变性新药试验
Factors in Learning And Plasticity: Macular Degeneration
不适用招募中美国NCT05454124Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
III 期招募中美国Argentina澳大利亚BulgariaNCT07064759A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
II 期招募中美国IsraelNCT05626114Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
IV 期招募中中国NCT07133438Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
I 期 / II 期招募中IndiaNCT06394232Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
早期 I 期招募中中国NCT07053358A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
II 期招募中美国中国Czechia德国NCT06962839Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
不适用招募中美国NCT07577219Visual Rehabilitation and Depression in Visually Impaired Patients With AMD
不适用招募中意大利NCT06906003Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
II 期招募中美国Austria加拿大CzechiaNCT06659445A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
不适用招募中美国中国NCT06346600A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
III 期招募中AustriaCzechiaDenmark法国NCT06847542
年龄相关性黄斑变性试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。